Tumor-derived lactic acid efficaciously reduces the activity of monocarboxylate transporter -1, which weakens cellular metabolism and diminishes the cytotoxicity of IFN-γ, granzymes, and perforin in CTLs (58). This evidence concerns the gene PRF1 and neoplasm.